Wed, June 19, 2019
Tue, June 18, 2019
Mon, June 17, 2019
Fri, June 14, 2019
Thu, June 13, 2019
Wed, June 12, 2019
Tue, June 11, 2019
Mon, June 10, 2019
Fri, June 7, 2019
Thu, June 6, 2019
Wed, June 5, 2019
Tue, June 4, 2019
Mon, June 3, 2019
Fri, May 31, 2019
Thu, May 30, 2019
Wed, May 29, 2019
Tue, May 28, 2019
Fri, May 24, 2019
Thu, May 23, 2019
Wed, May 22, 2019
Tue, May 21, 2019
Mon, May 20, 2019
Fri, May 17, 2019
Thu, May 16, 2019
Wed, May 15, 2019

Liana Moussatos Maintained (ASND) at Buy with Increased Target to $223 on, Jun 3rd, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-223-on-jun-3rd-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Liana Moussatos of Wedbush, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $219 to $223 on, Jun 3rd, 2019.

Liana has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with Liana's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Liana


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $144 on, Friday, May 31st, 2019
  • Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $139 on, Friday, March 29th, 2019

Publication Contributing Sources

Similar Stocks and Investing Publications